Polysaccharide nanoparticles as potential immune adjuvants: Mechanism and function.

Area of Science:

• Vaccinology
• Immunology
• Nanotechnology

Background:

• Adjuvants are crucial for vaccine efficacy, but polysaccharides face limitations in human use.
• Nanoparticles offer dual roles as antigen carriers and intrinsic adjuvants.
• Polysaccharide nanoparticles demonstrate superior immunostimulatory potential compared to native polysaccharides.

Purpose of the Study:

• To review the adjuvant function and mechanism of polysaccharide nanoparticles.
• To highlight their enhanced immunomodulatory properties.
• To guide their development as potent vaccine adjuvants.

Main Methods:

• Literature review of studies on polysaccharide nanoparticles as vaccine adjuvants.
• Analysis of data on humoral, cellular, and mucosal immune responses.
• Discussion of proposed immune signaling pathways (e.g., cGAS-STING, NLRP3, TLRs).

Main Results:

• Polysaccharide nanoparticles significantly enhance antigen-specific immune responses.
• They exhibit superior adjuvant effects across humoral, cellular, and mucosal immunity.
• Evidence suggests involvement of multiple immune pathways in their action.

Conclusions:

• Polysaccharide nanoparticles represent a promising class of vaccine adjuvants.
• Their nanoparticle form amplifies adjuvant potency.
• Further investigation into their mechanisms is essential for optimized vaccine design.